CytomX Therapeutics, Inc.CTMXNASDAQ
Loading
Enterprise value to sales ratio
5Y CAGR
+30.9%/yr
Long-term compound
Percentile
P58
Within normal range
vs 5Y Ago
3.8x
Strong expansion
Streak
1 yr
Consecutive growthElevated
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 7.60 | +1700.3% |
| 2024 | 0.42 | -61.6% |
| 2023 | 1.10 | +183.0% |
| 2022 | -1.32 | -152.6% |
| 2021 | 2.52 | +27.3% |
| 2020 | 1.98 | -47.4% |
| 2019 | 3.76 | -41.4% |
| 2018 | 6.41 | -24.3% |
| 2017 | 8.48 | -56.6% |
| 2016 | 19.52 | - |